US Patent 8435554 Compositons for nasal administration of pharmaceuticals
Patent 8435554 was granted and assigned to Shin Nippon Biomedical Laboratories on May, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+368 characters)
Article
Patent abstract
Compositions for nasal administration, which comprise a pharmaceutical, a physiologically active peptide, or a peptide-related compound, and as the carrier thereof, crystalline cellulose with a specific particle diameter and/or partially pregelatinized starch are provided. Such compositions improve the in vivo absorption efficiency of pharmaceuticals.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08435554 Compositons for nasal administration of pharmaceuticals US Patent 8435554 Compositons for nasal administration of pharmaceuticals
Infobox
Patent Number
0843555400
Patent Number
843555400
Edits on 8 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084355540
Date of Patent
May 7, 2013
0Patent Application Number
123465370
Date Filed
December 30, 2008
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084355540
Date of Patent
May 7, 2013
0Patent Application Number
123465370
Date Filed
December 30, 2008
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08435554 Compositons for nasal administration of pharmaceuticals
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08435554
Date of patent
May 7, 2013
Patent application number
12346537
Date Filed
December 30, 2008
Patent primary examiner
Find more entities like US Patent 8435554 Compositons for nasal administration of pharmaceuticals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.